title: Reply to letter: Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel.
authors.affiliation: Movement Disorder Center, Neurology, Campus Bio-Medico of Rome University, Rome, Italy.
authors.forename: Massimo
authors.initials: M
authors.lastname: Marano
authors.affiliation: Movement Disorder Center, Neurology, Campus Bio-Medico of Rome University, Rome, Italy.
authors.forename: Gaetano
authors.initials: G
authors.lastname: Salomone
authors.affiliation: Movement Disorder Center, Neurology, Campus Bio-Medico of Rome University, Rome, Italy.
authors.forename: Lazzaro
authors.initials: L
authors.lastname: di Biase
authors.affiliation: Movement Disorder Center, Neurology, Campus Bio-Medico of Rome University, Rome, Italy.
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Di Lazzaro
authors.affiliation: Movement Disorder Center, Neurology, Campus Bio-Medico of Rome University, Rome, Italy; Movement Disorder Service, Neurology, Azienda ospedaliera di Treviglio, Treviglio, BG, Italy. Electronic address: jmmelgari@tiscali.it.
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Melgari
mesh_terms: D000978:Antiparkinson Agents / Q000008:administration & dosage*; D002230:Carbidopa / Q000008:administration & dosage*; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage*; D008297:Male; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa; D002230:Carbidopa
keywords: Behavior; Dopamine agonist withdrawal syndrome; DuoDopa; Impulse control disorder (ICD); Punding